NEW YORK (GenomeWeb) – The Gene Editing Institute of the Helen F. Graham Cancer Center has signed an agreement to provide gene editing services and genetically modified cell lines to Analytical Biological Services (ABS), the partners announced today.

Under the terms of the three-year deal, the Gene Editing Institute will be the sole provider of gene editing services and genetically modified cell lines to ABS for replication, marketing, and distribution to pharmaceutical and biomedical research companies worldwide.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.